BioSpace News Archive

Atox Bio Closes $30M Investment

The round was led by Arix Bioscience with participation from Adams Street Partners, Asahi Kasei and additional undisclosed investors.

December 4, 2017
·
3 min read
Business

Alligator Bioscience Expands Management Team

Dr Russell will be responsible for leading Alligator’s clinical team in progressing the company’s immuno-oncology projects towards proof of concept in cancer patients.

December 4, 2017
·
2 min read
Moffitt Cancer Center Treats First U.S. Patient With Newly FDA-Approved CAR-T Therapy

As commercial use for Yescarta gets underway, Moffitt is actively enrolling eligible patients, with ten individuals awaiting treatment.

December 4, 2017
·
3 min read
Drug Development

Zynerba Pharmaceuticals Announces New ZYN002 Data From STAR 1 and STAR 2 Studies in Patients With Focal Seizures at the 2017 Annual Meeting of the American Epilepsy Society (AES)

The key findings include that clinically meaningful responses to ZYN002, as measured by reductions in focal seizures from the baseline period of STAR 1, are correlated with continued treatment with ZYN002.

December 4, 2017
·
9 min read
Policy

Propanc Biopharma Advances Towards GMP Manufacture of PRP for Human Trials

PRP is a solution for once-daily intravenous administration of a combination of two pancreatic proenzymes trypsinogen and chymotrypsinogen.

December 4, 2017
·
6 min read
Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10M in Series B Funding

SBI Japan-Israel Innovation Fund and Milestone Venture also participated in the round.

December 4, 2017
·
3 min read
Drug Development

Spruce Biosciences Receives FDA Orphan Drug Designation for SPR001 for the Treatment of Congenital Adrenal Hyperplasia

Spruce Biosciences today announced that the FDA has granted orphan drug designation for SPR001 for the treatment of congenital adrenal hyperplasia.

December 4, 2017
·
2 min read
Policy

Breckenridge Pharmaceutical Announces Final Approval of its ANDA Megestrol Acetate Oral Suspension (Megace ES)

The company will launch immediately.

December 4, 2017
·
1 min read
Genetown

Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

These awards were granted pursuant to the Paratek Pharmaceuticals, Inc. 2017 Inducement Plan.

December 4, 2017
·
4 min read
NW Bio Announces Completion of $12M Financing

The financing is in the form of Series A Convertible Preferred Stock and Warrants.

December 4, 2017
·
4 min read